Latest filing published 27 Mar 2017 for Palisade Bio, INC., €28k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -69.4%Entry US$482,400.00 · Close at T+365 US$147,600.00
- -69.2%Entry US$374,400.00 · Close at T+365 US$115,200.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jones Jonathan Brian Lloyd: trading record in brief
Jones Jonathan Brian Lloyd discloses dealings in 2 companies, chiefly Juniper Pharmaceuticals Inc and Palisade Bio, Inc. In total, 6 filings cover trades dated from 14 May 2013 to 24 March 2017.
The open-market record is one-sided, with 4 purchases worth €48k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 2 option exercises. So far in 2017, the count stands at 1 purchase and no sales.
In size, the median ticket on the buying side is €8,151.
The newest entry dates from 27 March 2017: an open-market purchase of €28k, in Palisade Bio, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jones Jonathan Brian Lloyd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,455 shares@ US$5.5075.7% of flowCommon StockSEC:0001171843-17-001771:0Canonical exit: 22 Jun 2017 (T+90)
- 31,250 shares@ US$0.3224.3% of flowCommon StockSEC:0001171843-16-012275:0Canonical exit: 22 Dec 2016 (T+90)
- 1,000 shares@ US$5.04$0.01 par value Common StockSEC:0001181431-14-017862:0
- 2,000 shares@ US$5.04$0.01 par value Common StockSEC:0001181431-14-012315:0
- 1,580 shares@ US$6.32CBRX stock on Open MarketSEC:0001181431-13-060669:0Canonical exit: 24 Feb 2014 (T+90)
- 8,000 shares@ US$0.625CBRX stock on Open MarketSEC:0001181431-13-027567:0Canonical exit: 12 Aug 2013 (T+90)
6 of 6 declarations